Semaglutide increased maximum walking distance by 13% compared with placebo. Treatment with semaglutide improved maximum walking distance in patients with type 2 diabetes (T2D) and symptomatic ...

Semaglutide, more commonly known as Ozempic, can do more than help with weight loss. A new clinical trial shows it helps treat poor blood flow in diabetic patients, which could otherwise lead to ...

One of the most interesting items of note is a new camera peripheral simply called the Nintendo Switch 2 Camera. This will allow users to perform several functions, including place their face on ...

CHICAGO — Semaglutide, a glucagon-like peptide (GLP-1) receptor agonist, has shown convincing benefits in yet another population: patients with peripheral arterial disease (PAD). In the STRIDE ...

Ozempic improved walking distance in patients with diabetes and peripheral artery disease at 1 year. An exploratory analysis suggested Ozempic reduced risk for major limb events and mortality.

Jon Stewart is warning Democrats and other critics of Donald Trump against overusing their claims of authoritarianism after the president's first week in office, which included a slew of executive ...

Turnover recently announced that they’d celebrate the 10th anniversary of their game-changing 2015 album Peripheral Vision by performing it in full at select shows this year, many of which sold ...

Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial. Nature Communications , 2024; 15 (1) DOI: 10.1038/s41467-024-49092-5 Cite This Page : ...

As expected, walking speed declined in those who took a placebo, because peripheral artery disease causes progressive declines in walking performance. This is a signal that nicotinamide riboside ...

A new review paper was published in Aging titled "Peripheral vascular dysfunction and the aging brain." Aging is the greatest non-modifiable risk factor for most diseases, including cardiovascular ...